These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 12016143)
21. The transcriptional repressor of p16/Ink4a, Id1, is up-regulated in early melanomas. Polsky D; Young AZ; Busam KJ; Alani RM Cancer Res; 2001 Aug; 61(16):6008-11. PubMed ID: 11507043 [TBL] [Abstract][Full Text] [Related]
22. Forced expression of the cyclin-dependent kinase inhibitor p16(INK4A) in leukemic U-937 cells reveals dissociation between cell cycle and differentiation. Bergh G; Telleus A; Fritzon A; Kornfält S; Johnson E; Olsson I; Gullberg U Exp Hematol; 2001 Dec; 29(12):1382-91. PubMed ID: 11750096 [TBL] [Abstract][Full Text] [Related]
23. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705 [TBL] [Abstract][Full Text] [Related]
24. The helix-loop-helix protein id-1 delays onset of replicative senescence in human endothelial cells. Tang J; Gordon GM; Nickoloff BJ; Foreman KE Lab Invest; 2002 Aug; 82(8):1073-9. PubMed ID: 12177246 [TBL] [Abstract][Full Text] [Related]
25. Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells. Ling MT; Wang X; Ouyang XS; Xu K; Tsao SW; Wong YC Oncogene; 2003 Jul; 22(29):4498-508. PubMed ID: 12881706 [TBL] [Abstract][Full Text] [Related]
26. Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas. Nakamura M; Sakaki T; Hashimoto H; Nakase H; Ishida E; Shimada K; Konishi N Cancer Res; 2001 Sep; 61(17):6335-9. PubMed ID: 11522621 [TBL] [Abstract][Full Text] [Related]
27. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53. Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969 [TBL] [Abstract][Full Text] [Related]
28. Id-1-induced Raf/MEK pathway activation is essential for its protective role against taxol-induced apoptosis in nasopharyngeal carcinoma cells. Cheung HW; Ling MT; Tsao SW; Wong YC; Wang X Carcinogenesis; 2004 Jun; 25(6):881-7. PubMed ID: 14742319 [TBL] [Abstract][Full Text] [Related]
29. Up-regulation of TRPM-2, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the Noble rat. Ouyang XS; Wang X; Lee DT; Tsao SW; Wong YC Carcinogenesis; 2001 Jun; 22(6):965-73. PubMed ID: 11375906 [TBL] [Abstract][Full Text] [Related]
30. Over expression of ID-1 in prostate cancer. Ouyang XS; Wang X; Lee DT; Tsao SW; Wong YC J Urol; 2002 Jun; 167(6):2598-602. PubMed ID: 11992094 [TBL] [Abstract][Full Text] [Related]
31. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation. Zhuang SH; Burnstein KL Endocrinology; 1998 Mar; 139(3):1197-207. PubMed ID: 9492054 [TBL] [Abstract][Full Text] [Related]
32. Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression. Coppe JP; Itahana Y; Moore DH; Bennington JL; Desprez PY Clin Cancer Res; 2004 Mar; 10(6):2044-51. PubMed ID: 15041724 [TBL] [Abstract][Full Text] [Related]
33. Cell cycle dysregulation influences survival in high risk breast cancer patients. Königsberg R; Rögelsperger O; Jäger W; Thalhammer T; Klimpfinger M; De Santis M; Hudec M; Dittrich C Cancer Invest; 2008 Aug; 26(7):734-40. PubMed ID: 18665474 [TBL] [Abstract][Full Text] [Related]
34. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma. Okami K; Reed AL; Cairns P; Koch WM; Westra WH; Wehage S; Jen J; Sidransky D Oncogene; 1999 Jun; 18(23):3541-5. PubMed ID: 10376532 [TBL] [Abstract][Full Text] [Related]
35. Mel-18 negatively regulates INK4a/ARF-independent cell cycle progression via Akt inactivation in breast cancer. Lee JY; Jang KS; Shin DH; Oh MY; Kim HJ; Kim Y; Kong G Cancer Res; 2008 Jun; 68(11):4201-9. PubMed ID: 18519679 [TBL] [Abstract][Full Text] [Related]
36. Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes. Singh RP; Agarwal C; Agarwal R Carcinogenesis; 2003 Mar; 24(3):555-63. PubMed ID: 12663518 [TBL] [Abstract][Full Text] [Related]
37. Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cells. Schwarze SR; Shi Y; Fu VX; Watson PA; Jarrard DF Oncogene; 2001 Dec; 20(57):8184-92. PubMed ID: 11781834 [TBL] [Abstract][Full Text] [Related]
38. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1. Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671 [TBL] [Abstract][Full Text] [Related]
39. Analysis of p53, p16(INK4a), pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas. Bilyk OO; Pande NT; Buchynska LG Exp Oncol; 2011 Sep; 33(3):150-6. PubMed ID: 21956468 [TBL] [Abstract][Full Text] [Related]
40. Inactivation of Id-1 in prostate cancer cells: A potential therapeutic target in inducing chemosensitization to taxol through activation of JNK pathway. Zhang X; Ling MT; Wang X; Wong YC Int J Cancer; 2006 Apr; 118(8):2072-81. PubMed ID: 16287090 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]